688177 Bio-Thera Solutions,
- 21.65
- +0.28+1.31%
Bio-Thera Solutions, News
Biotech voluntarily disclosed information about its relationship with Gedeon Richter Plc. (Jiri Pharmaceuticals) Progress Notice on Signing a License and Receiving Down Payments and Milestone Payments for BAT2206 (usinumab) injections and production, supply and commercialization agreements
Biotech About Gedeon Richter Plc (Jiri Pharmaceuticals) Announcement on the signing of licensing and production, supply and commercialization agreements for BAT2206 (usinumab) injection
Bio-Thera Solutions' Announcement on the Approval of Avzivi (Bavencio Injection) by the European Commission
Bio-Thera Solutions voluntarily disclosed the announcement about milestone payment received for the authorization and commercialization agreement signed with Hikma Pharmaceuticals USA Inc. regarding BAT2206 (ustekinumab injection).
Bio-Thera Solutions voluntarily announced the progress of receiving the first payment for the BAT2506 (Golimumab injection) licensing and commercialization agreement with STADA.
Bio-Thera Solutions' announcement regarding the approval of TOFIDENCE (toripalimab injection) by the European Commission.
Bio-Thera Solutions voluntarily disclosed an announcement about the positive opinion of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) on AVZIVI (bevacizumab injection).
Biotech's announcement on signing a licensing and commercialization agreement with STADA for BAT2506 (golimumab) injection
Biotech's announcement on acceptance of the marketing license application for BAT2206 (usinumab) injection
Biotech voluntarily disclosed an announcement on TOFIDENCE (tocilizumab injection) receiving positive opinions from the European Medicines Agency's Human Medicines Committee
Announcement of Resolutions of Biotech's 2023 Annual General Meeting of Shareholders
Legal Opinion of Biotech's 2023 Annual General Meeting of Shareholders
Biotech's 2023 Annual General Meeting of Shareholders Meeting Materials
Baiaotai's Notice on Convening the 2023 Annual General Meeting of Shareholders
Baiaotai's announcement on the use of some temporarily idle funds raised and part of its own funds for cash management
Biotech's 2023 Internal Control Evaluation Report
Biotech's 2023 Board Audit Committee Performance Report
Report of the Biotech Audit Committee on the performance of supervisory duties by accounting firms in 2023
Biotech's 2024 “Improve Quality, Increase Efficiency, and Value Return” Action Plan
Baiaotai's announcement on the company's 2024 remuneration plan for directors, supervisors and senior management
Analysis
Price Target
No Data
No Data